gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · INBSHealthcareSurgical Instruments

Intelligent Bio Solutions Inc. Common Stock (INBS)

$1.75−1.13%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$1.75▼ 79.25% in range
Nov 4, 2025Low $1.44 · High $17.92Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Intelligent Bio Solutions closed at $1.75 on Nov 4, down 1.13%, 90.2% below its 52-week closing high. Volume of 19.0K shares was 0.52× its 20-day average (below normal).

Split-adjusted performance: +10.8% over one month, -27.4% over six months, -81.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $1.15M, up 35.8% from a year earlier, with a net margin of -341.0%.

Short interest was 91.1K shares at the Oct 15 settlement, up 56.3% from the prior report (2.8% of float, 1.4 days to cover).

Market cap$5.8M3.3M shares
Revenue · quarter$1.1M+35.8% YoY
Diluted EPS$-1.57—
P/E · TTM—P/S 1.4×
Net margin-341.0%Gross 46.8%
Dividend yieldNone
52-week range1.44 – 17.92−90.2% from high
Volume19.0K0.52× 20-day avg
Volatility · 60d98.2%Annualised
Short % of float2.8%1.4 days to cover
Net cash$4.0MCash $4.0M
Next earnings—Not scheduled
Split-adjusted performance
1W +4.8%1M +10.8%3M −12.1%6M −27.4%YTD −81.6%1Y −81.1%3Y −93.7%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum32
Revenue growth89
Net margin15
Value (low P/E)—
Size13

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short91.1K+56.3% vs prior
Days to cover1.4Settled Oct 15
% of float2.8%
Short vol. 10d53.1%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
INBSIntelligent Bio Solutions$1.75−1.13%−27.4%+35.8%−341.0%—$5.8M
SNOASonoma Pharmaceuticals$1.11−2.63%−6.7%+59.6%−5.2%—$5.3MCompare
TNONTenon Medical$1.91+1.06%−92.7%+126.8%−316.7%—$5.1MCompare
CNSYCerenome$0.8916−31.42%————$6.8MCompare
NVNOenVVeno Medical$7.00−2.43%−30.5%———$4.9MCompare
AEMDAETHLON MEDICAL$5.75−0.86%−51.7%———$4.1MCompare
NMTCNeuroOne Medical Technologies$0.9500−3.06%−77.9%+16.3%−101.7%—$8.7MCompare
CODXCo-Diagnostics$0.3614−4.89%—+2.0%−3782.4%—$3.2MCompare
AMIXAutonomix Medical$1.61−3.01%−80.1%———$3.2MCompare

News about Intelligent Bio Solutions

All news →

No recent articles focused on Intelligent Bio Solutions.

Quick answers

What does Intelligent Bio Solutions do?
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader.
What is INBS's market cap?
$5.80M, based on the Nov 4 close of $1.75.
Does Intelligent Bio Solutions pay a dividend?
No regular cash dividend has been paid in the last year.
How much of INBS is sold short?
91.1K shares, 2.8% of float, as of Oct 15, 2026.
What sector is INBS in?
Healthcare, in the Surgical Instruments industry.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

HQ: New York, NY60 employeesListed Dec 23, 2020ibs.inc

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology